Immunoprecipitation using Dynabeads® Protein A or G
Immunoprecipitation is going magnetic!
While agarose / sepharose slurry worked great when you wanted to purify large amounts of protein or antibody, it turned out not to be so well suited for the smaller scale isolation of specific proteins and protein complex.
True or False?
Do these assumptions hold true?
Are You Still Using Sepharose®/Agarose Slurry?
Thousands of scientists are moving away from Sepharose® and agarose. They now prefer to use magnetic beads.
Figure 1: Dynabeads® magnetic separation is the fastest growing method for immunoprecipitation. Graphs show percent increase/decrease of published papers using agarose (green), sepharose (blue) and Dynabeads® (red). Source: Google Scholar, Feb. 2011. Sepharose® is a trademark of GE Healthcare companies.
What is Most Important for Immunoprecipitation?
These are the main reasons why scientists now prefer to use Dynabeads® for their immunoprecipitaion.
The protocol is fast and simple, and the results are great. What more could you want?!
Minimal non-specific binding
|Signal to Noise|
Easy and efficient washing
Magnetic separation protocol
All binding on outer surface
|Time and Effort|
30 minutes start to finish
Product and handling consistency
Listen to What Your Colleagues are Saying:
An increasing number of scientists now prefer to use magnetic beads for their immunoprecipitation.
|Watch Video |
How to avoid two typical problems:
Left Image: Loss of sepharose & sample
Immunoprecipitation on BenchPaper -
An Exciting Shift!
Bring Your Research Tools up to Date!
Magnetic handling is easy, fast and efficient. Bound only by affinity interactions, your protein and protein complexes are preserved intact.
Other advantages of using Dynabeads® for immunoprecipitation include:
- No columns or centrifugations.
- No time-consuming sample pre-treatment.
- No loss of target protein.
- Maximum sensitivity.
- Starting sample can be saliva, plasma, ascites, serum, and tissue culture or hybridoma supernatants.
Shorter Protocol Time. Better Yield and Reproducibility with Dynabeads Immunoprecipitation Kit
Table 1 - Properties of the Recombinant Protein A and Protein G in Dynabeads®
Dynabeads® Protein A and Dynabeads® Protein G bind with different affinities depending on the immunoglobulin type and species. Binding occurs mainly through the Fc region. The binding capacity will depend on the initial concentration of antibodies in the sample and the source of the antibody. These data are based on isolation from a sample containing 100 µg immunoglobulin per ml.
|Protein A||Protein G|
|Molecular weight||45 kDa||17 kDa|
|No.of binding sites for IgG||4||2|
|Binding capacity*||250 µg human|
IgG / ml beads
|640 µg mouse|
IgG / ml beads
|Optimal binding pH||7.4||7.4|
Additional Information About Immunoprecipitation
The recombinant protein A/G on the beads contains no albumin binding sites, thus avoiding co-purification of contaminating proteins. Binding of antibodies to the beads in solution is an equilibrium reaction. To capture as many antibodies as possible, the reaction volume should be kept low to maintain high concentrations of beads and antibody. There is no need for pre-treating the sample (even viscous samples), hence no dilution of sample or beads should be done. If the antibody concentration in the sample is suspected to be very low, the amount of beads can be increased.
As an alternative to eluting antibody from the beads, the Dynabeads® may be re-suspended in a Na-phosphate buffer (Figure 3). To prevent co-elution, it is possible to cross-link the antibody to protein A/G on the beads prior to immunoprecipitation. This is not necessary for downstream SDS-PAGE followed by autoradiography or western blotting, and optional for Silver or Coomassie® staining.
Figure 3 - Protein elution properties
Affinity purification of human IgG
Figure 4 - Affinity purification of human IgG and immunoprecipitation of human serum albumin from 2 µl serum, using Dynabeads® Protein A. Lane 1 - Purified IgG from serum. Lane 2: Immunoprecipitated human serum albumin (cross-linking omitted thus antibody present). Lane 3: 50 x diluted serum. Lane 4: LMW.